Management Forum courses now available at IPI Academy - visit IPI for an updated experience and a broader selection of courses and subjects
  • Home
  • An Essential Overview of the Pharmaceutical and Biotech Industries

An Essential Overview of the Pharmaceutical and Biotech Industries Training Course

This programme will give you an invaluable overview of the pharmaceutical industry, from discovery of the molecule through development to marketing.

1 Mar 2022

& 16 Sep 2022

Book now


Course overview

The pharmaceutical and biotechnology industries are both complex and developing at a rapid pace. This intensive one-day course will give you an invaluable overview, refresher and update on all the important aspects from discovery of the molecule through development to marketing. The interactive programme will provide a step-by-step understanding of the main areas of drug development and will discuss the roles and responsibilities of key departments and how they work and interact together. You will be given a comprehensive glossary of the most commonly used industry terms, which will be a useful reference to help you get to grips with the technical terminology and jargon.

There will be interactive discussion sessions throughout the day, led by our expert course leader, and you will come away with a good knowledge of the structure and function of these industries.

Who should attend?

This event will be of interest to all those looking to develop their knowledge of how the pharma/biotech industries work. It will be particularly helpful for those wanting to understand what other departments do, for new staff working in the industry and for non-scientific and administrative personnel.

Why you should attend

  • Increase your understanding of the pharma/biotech industries
  • Develop your knowledge of the stages of drug development from drug discovery through to marketing
  • Get to grips with the phases of clinical trials, regulatory processes and pharmacovigilance requirements
  • Understand the roles and responsibilities of key departments and how they work together
  • Demystify the technical terminology and jargon


How the pharma/biotech industries develop medicines

  • Overview of drug development
  • Framework of the industry – research, development and manufacture of pharma products on an international level
  • Difference between pharma and biotech drug development
  • Drug discovery
  • Non-clinical/pre-clinical – the importance of examining safety
  • Technologies and innovations across the industry
  • Strategy and the targeted product profile

Demystifying the jargon and terminology

Roles and responsibilities of the people in the pharma/biotech industries

Clinical trials

  • Phases of clinical research – phase 1 to phase IV and range of clinical trials
  • Setting up and running of clinical trials
  • Quality of the data – monitoring, auditing and compliance with GCP innovations in running clinical trials


  • Understanding pharmacovigilanceSafety reporting and signal detection
    • Evaluation and risk management plans
    • Periodic and drug safety update reports

Regulatory processes

  • Overview of regulatory submissions and approval procedures for pharma/biotech products
  • EU and FDA accelerated procedures
  • The importance of ICH
  • ICH and the electronic Common Technical Document (eCTD)
  • The EU Clinical Trial Regulation
  • Update on the impact of Brexit

Commercial considerations for how medicines are marketed and sold

  • Marketing terminology and activities


Laura Brown (More...)

Dr Laura Brown is a pharmaceutical management consultant and Senior Lecturer of the MSc in Clinical Research at the School of Pharmacy, University of Cardiff and course director MSc Regulatory Affairs, TOPRA. Laura has more than 25 years’ experience in the pharmaceutical industry and has held senior positions with companies such as GSK, Hoechst Marion Roussel, Farmitalia and Phoenix International. She regularly writes on pharmaceutical drug development and regulatory issues including ‘The Planning of International Drug Development’ in the Clinical Research Manual and ‘The Impact of Brexit’ in the RQA journal.

Book now

Book now

1 Mar 2022
Live webinar
1 Mar 2022
Live webinar
GBP 599 499
EUR 859 719
USD 970 814
Until 25 Jan 22*
Enrol now
to attend
Live webinar
16 Sep 2022
Live webinar
16 Sep 2022
Live webinar
GBP 599 499
EUR 859 719
USD 970 814
Until 12 Aug 22*
Enrol now
to attend
Live webinar

Learn more about our face-to-face and webinar training formats.

* Note the early booking discount cannot be combined with any other offers or promotional code

Continuing professional development

This course qualifies for 6 hours for your CPD records.
More about CPD

Customised in-house training

We can customise this course to meet the requirements of your organisation and deliver it at your location and/or online.

Contact us

You may also be interested in

Previous customers include...

  • (MHRA) Medicines & Healthcare Products Regulatory Agency
  • Abbott EPD
  • Actavis Plc
  • Allergan
  • Arriello Ireland Limited
  • Biogen Idec Limited
  • Boehringer Ingelheim Vetmedica GmbH
  • Brecon Anderson UK Ltd
  • Charles Russell Speechlys LLP
  • Chiesi Farmaceutici S.p.a.
  • Chugai Pharma UK Ltd
  • Datapharm Communications Ltd
  • Digiweb Ltd
  • Gilead Sciences
  • Hospira UK Ltd
  • Intercept Pharma Europe Ltd
  • Intercept Pharmaceuticals
  • IPSEN Pharma
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • MHRA
  • Monachem
  • Norgine
  • PCI Pharma Services T/A Millmount Healthcare
  • Pharmiweb Solutions
  • Pliva Croatia d.o.o.
  • Pliva Croatia Ltd
  • Presspart
  • PSE Ltd
  • UCB Pharma SA
  • UCL

All fine

Jusna Begum, Medical Operations Coordinator, GW Pharmaceuticals PLC, May 21

I was impressed and happy with the content, presentation and speakers. [Laura] was very good and the training was interesting and even though it was a full day, it never felt boring or dull.

Cleagh Sinclair, Associate Director Business Development, Certara Germany GmbH, May 21

Nice and interesting presentation

Charlotte Billy, Biostatatiscien, Ceva Santé Animal, May 21

A very well run course, speaker was excellent and thoroughly enjoyed the course.

Sarah Robbins, HR Advisor, PCI Pharma Services, May 21

The course exceeded my expectations. The course tutor was fantastic, covering a lot of information with a great tone, humour (at the right times) and interaction throughout. I really enjoyed the course and would recommend to others. Overall, an excellent day's training, managed very well by an obvious industry expert, with a great opportunity to network with industry people.

Andrew Veevers, Learning Development Manager, Brecon Anderson UK Ltd, Oct 19

I enjoyed the course and particularly liked the small group and interactive exercises. It was very useful in terms of content and information, well presented, speaker was good and had a lot of knowledge on the subject.

Andria Pelava, Development Scientist, Iksuda Therapeutics, Oct 19

Laura is great, very engaging and knowledgeable! I really enjoyed this training and will recommend it to my colleagues!

Katarzyna Mendela, Finance Assistant, PSE Ltd, Oct 19

Laura was very attentive to the delegates' diverse work experiences and expectations and so knowledgeable!

Catherine Jeannot, Language Teacher-Pharmacy Faculty, Université Paris Sud, Nov 18

The course was well organised, covered all areas of interest. The speaker had a lot of knowledge on the subject and she delivered the information well.

Yulia Degtyareva, Scientist, Philips, Nov 18

The speaker was very engaging, easy to listen to and made the course content easy to understand for newcomers - no jargon!

Tasmin Morgan, Operations Manager, Ridge Pharma, Nov 18

A clear presentation . Speaker was pertinent and has an expert knowledge in pharmaceutical industry, updates the current events

Lingling DAI, Business Development Manager, LFB Biomedicament, Nov 18

I found the course very informative and enjoyable, Laura was very knowledgeable and made everything easy to understand.

Emily MacKenzie, Sponsorship and Partnerships Manager, British Society for Rheumatology, Nov 18

Very well organised course, with a very knowledgable and friendly presenter giving clear and concise information. Very useful to people new to the industry and a good revision for others.

Shona Rhydderch, Analytical Chemist, TauRx Therapeutics Ltd, Nov 17

Very enjoyable overall, I feel this will help my learning and development

Tanya Killick, Medical Administrative Associate, Vertex Pharmaceuticals (Europe) Limited, Nov 17

All areas were excellent. The booklet accompanying the presentation was very helpful

Grace McIntyre, Warehouse Technician, GW Pharmaceuticals, Nov 17